Volume 29, Number 3—March 2023
Research Letter
Recurrent Cellulitis Revealing Helicobacter cinaedi in Patient on Ibrutinib Therapy, France
Figure 1

Figure 1. Recurrent skin manifestations revealing Helicobacter cinaedi bacteremia in a man on ibrutinib therapy for chronic lymphocytic leukemia, France. A bright red, slightly painful lesion with a sharp border was localized on the left thigh.
Page created: January 27, 2023
Page updated: February 20, 2023
Page reviewed: February 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.